AI assistant could sharpen eye injection choices
NCT ID NCT07328776
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests an artificial intelligence system called QiLin that helps doctors decide when to give anti-VEGF injections for retinal diseases like wet AMD, DME, and RVO. About 200 patients who have completed initial treatment will be randomly assigned to have their doctor use the AI or not. The main goal is to see if AI-assisted decisions match expert recommendations more often than doctor-only decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- QiLin artificial intelligence system
- What this could lead to
- If successful, this AI tool could help doctors make more accurate decisions about anti-VEGF injections, potentially improving outcomes for patients with retinal diseases.
- What could go wrong
- This is an early-stage trial with 200 participants. The AI may not perform as well in real-world settings as in lab tests, and its benefit over standard care is unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai general hospital
Shanghai, China
-
Shanghai general hospital, Shanghai Jiao Tong University, Shanghai, 200080
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could eye drops replace injections for a leading cause of blindness?
- Could a daily eye gel replace injections for wet AMD?
- Longer-Lasting eye injection could cut treatment visits for macular disease
- Can a new eye drug cut injection frequency for AMD patients?
- Should gene therapy be used for AMD? new study asks patients
- New eye injection could reduce treatment frequency for wet AMD